Aquestive Therapeutics, Inc.
AQSTDrugs in Pipeline
5
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How AQST's past catalysts played out
Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category
Epilepsy
Diazepam Buccal Film 12.5 mg
Epilepsy
Diazepam Buccal Film
Epilepsy
Diastat® Rectal Gel (Valeant Pharmaceuticals USA)
Epilepsy
DESF
Allergic Reaction
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category | Phase 3 | Epilepsy | - | - |
Diazepam Buccal Film 12.5 mg | Phase 2 | Epilepsy | - | - |
Diazepam Buccal Film | Phase 2 | Epilepsy | - | - |
Diastat® Rectal Gel (Valeant Pharmaceuticals USA) | Phase 2 | Epilepsy | - | - |
DESF | Phase 2 | Allergic Reaction | - | - |
Frequently asked questions
What is in Aquestive Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Aquestive Therapeutics, Inc.'s (AQST) pipeline across Phase 3, Phase 2. Its lead program is Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Aquestive Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Aquestive Therapeutics, Inc. (AQST) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AQST biotech catalysts?→
Add AQST to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Aquestive Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.